Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Molecular Genetics and Metabolism|June 24, 2014
A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestryJuyuan Guo, Gary S Johnson, Holly A Brown, et al.
The Journal of Comparative Neurology|March 28, 2006
Identification, physiological actions, and distribution of VYRKPPFNGSIFamide (Val1)-SIFamide) in the stomatogastric nervous system of the American lobster Homarus americanusAndrew E Christie, Elizabeth A Stemmler, Braulio Peguero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trialJ R Mackey, T Pieńkowski, J Crown, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policiesJ Gagnon, E Lévesque, , et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancerR Bell, J Brown, M Parmar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2014
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†M Piccart, G N Hortobagyi, M Campone, et al.
Breast Cancer Research and Treatment|December 28, 2014
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II studyA R Tan, H Johannes, P Rastogi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trialD Rayson, T M Suter, C Jackisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2025
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy-PENELOPE-BS Loibl, M Martin, H Bonnefoi, et al.
Pageof 4